MachineMD
machineMD is a Swiss medical device company developing innovative solutions for automated, quantitative neuro-ophthalmic diagnostics.
About
machineMD is a medical device company, based in Bern, Switzerland, with a mission to radically improve the measurement of brain function through innovative solutions at the intersection of neuroscience and ophthalmology. The company has developed neos™, the world’s first Neurophthalmoscope, a non-invasive medical device using a VR headset and AI to automate and quantify the assessment of eye movements, pupil function, and visual fields. By standardizing and automating these diagnostic tests, machineMD aims to enhance clinical efficiency, extend specialist-grade diagnostics to primary and secondary care, and improve early detection and monitoring of brain disorders such as stroke, multiple sclerosis, Parkinson’s disease, brain tumors, and more.
Products & Services
- neos™ Neurophthalmoscope (automated, VR-based diagnostic device for neuro-ophthalmic examinations)
- Automated eye movement and pupillometry assessment
- Quantitative visual field testing
- Cloud-based diagnostic reports and data management
- Research collaboration platform for neurological and ophthalmologic studies
Use Cases & Case Studies
- Automated, quantitative neuro-ophthalmic exams for diagnosis and monitoring of neurological diseases (Multiple Sclerosis, Parkinson’s, Brain Tumors, Myasthenia Gravis, Alzheimer’s, etc.)
- Clinical research studies (over 400 patient examinations reported at University Hospital Bochum)
- Use in telemedicine for remote neuro-ophthalmic assessments
- Published clinical studies on glaucoma management with VR-pupillography
- Automated measurement of strabismus angles with a VR headset
- Screening and monitoring of visual and oculomotor function in rare diseases
Partnerships & Collaborations
- Topcon Healthcare (lead investor and strategic partner integrating neurodiagnostics)
- Evoleen (software and cloud infrastructure)
- CSEM Neuchâtel (image processing and algorithmic development for diagnostics)
- Helbling AG (engineering development)
- University Hospital of Bern (clinical research and device development)
- University Hospital Zurich (clinical validation partner)
- Inselspital Bern (clinical studies and research partner)
- Von Hoff AG (Swiss distribution partner)
- University Hospital Zurich Eye Clinic (clinical usage)
- St. Josef-Hospital, Ruhr-University Bochum (clinical research using machineMD technology)
- gaitQ (joint research grant on Parkinson’s disease)
- MATTER Healthcare Innovation Hub
- Lundbeck US Charitable Fund
Awards & Recognition
- Ypsomed Innovation Award (2023, 1st Prize)
- Winner, VIVE XR Healthcare Challenge 2024
- Innovation World Cup 2023 Top Prize
- Runner-up, Bern Center for Innovation and Digitalization ‘Best Startup Team of the Year’ 2022
- Selected for Advancing Brain Health Innovation Challenge (MATTER/Lundbeck 2025)
- Finalist, DayOne 4.0 Health Accelerator 2024
- VSP Vision Innovation Challenge (2nd Place, 2024)
Contact Information
Certifications & Compliance
- EU-MDR Class IIa certification for neos™ (EU-2017/745 MDR, TÜV SÜD Danmark)
- ISO 13485:2016 Quality Management System certification (TÜV Italia)
- neos™ registered as a Class I medical device in USA
- Certified as Class IIa device under UK MHRA